From: Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus
toxin
HlgAB
HlgBC
mAbs
YG8–1
0.10
0.28
YG8–2
0.12
0.27
YG8–3
0.26
0.21